健身气功·易筋经锻炼对老年人身体机能和血脂的影响

目的:探讨健身气功.易筋经锻炼对老年人身体机能和血脂的影响。方法:以70名老年女性为对象,随机分为练功组(n=35)和对照组(n=35),练功组进行每周5次,每次60分钟,持续3个月的锻炼,对照组不参加任何集体或个人的有计划锻炼。分别于实验前和3个月练功后对实验对象的血压、肺活量、坐位体前屈、握力、背力、反应时、闭眼单腿站立、TC、TG、HDL、LDL测试。结果:练功3个月后,练功组舒张压显著降低(p<0.05),坐位体前屈明显增加(p<0.01)、背力增加(p<0.05)、反应时减少(p<0.05)、闭眼单腿站立时间明显增加(p<0.01),TG降低(p<0.05)、HDL升高(p<0.05)、LDL显著降低(p<0.01);对照组在实验前后所测指标均未发生明显变化(p>0.05)。结论:3个月的健身气功.易筋经锻炼,对老年女性的身体机能和血脂产生了积极的健身效果。     

内毒素诱导急性肺损伤小鼠支气管肺泡灌洗液中谷氨酸含量变化的初步研究

目的 观察LPS诱导急性肺损伤时肺内是否存在谷氨酸（Glu）的释放.方法 腹腔注射内毒素制备小鼠急性肺损伤模型,于6h后采用生理盐水行支气管肺泡灌洗,用高效液相色谱法测量灌洗液中氨基酸的浓度.结果 与生理盐水对照组相比,LPS处理组支气管肺泡灌洗液中Glu的浓度增高（P〈0.01）;苏氨酸、蛋氨酸及精氨酸的浓度降低（P〈0.05）,其它氨基酸浓度无显著性变化.结论 在LPS诱导的肺损伤过程中肺组织中部分氨基酸代谢发生显著变化,肺内谷氨酸的释放增多,进一步提示Glu参与了内毒素诱导的肺损伤的病理生理过程.     

DADS对人小细胞肺癌细胞株NCI—H446增殖的影响

目的探讨二烯丙基二硫（diallyldisulfide,DADS）体外抑制人肺癌细胞株NCI—H446细胞增殖作用。方法采用MTT、细胞计数、细胞活力检测DADS对体外培养的人肺癌H446细胞的抑制增殖作用;倒置显微镜观察DADS对体外培养的人肺癌H446细胞的形态学改变。结果IVIqT结果显示,DADS作用H446细胞后,明显抑制细胞增殖且抑制率呈现浓度时间依赖性关系;细胞计数结果表明,DADS作用H446细胞后其细胞群体倍增时间延长;形态学变化观察,随着DADS浓度递增,细胞逐渐稀疏,数量明显减少。结论DADS对人小细胞肺癌H446细胞株具有抗增殖作用,且与药物浓度及作用时间相关。     

叹气法肺复张对急性肺损伤疗效的研究

采用PCV(压力控制)模式,在吸气压力≤30 cmH2O(1 cmH2O=0.098 kPa)的条件下,使潮气量为6～8 mL/kg,对2006年11月至2008年11月河北省人民医院重症监护治疗病房收治的20例ALI(急性肺损伤)患者实施叹气法肺复张治疗,观察叹气法肺复张对ALI的疗效及对血流动力学的影响,为在临床使用叹气法肺复张提供依据。结果表明,持续的叹气能明显改善ALI患者的氧合状态及胸肺顺应性,同时安全易行,对血流动力学干扰较小。     

2016年值得记住的科技界声音

 2016年,科技工作者在各自的领域发出众多评述性或意见性的深刻“声音”。本文围绕引力波、“悟空”暗物质探测卫星、“墨子号”量子通信卫星、转基因等热点科技话题,摘选部分重要的科技界“声音”,分为科技创新、基础研究、大数据、人工智能与转基因技术5个主题,其中基础研究包含引力波、暗物质、量子技术、对撞机4个部分。     

培美曲塞二钠联合铂类二线治疗晚期非小细胞肺癌临床观察

目的：探讨培美曲塞二钠联合铂类方案二线治疗晚期非小细胞肺癌（NSCLC）的疗效和不良反应.方法：16例既往化疗失败的晚期NSCLC患者接受培美曲塞二钠联合铂类方案化疗,其中培美曲塞二钠500 mg/m^2加入0.9%氯化钠注射液100 ml静脉滴注超过10 min,第1天;顺铂75 mg/m^2或卡铂剂量AUC=5第2天,静脉滴注.每21 d重复,2周期评价疗效.结果：16例患者中,无CR病例,PR 2例,SD 8例,PD 6例,RR12.6%,DCR为62.5%.主要的不良反应是骨髓抑制、消化道反应和口腔粘膜炎,多为I-Ⅱ度,经对症治疗后可以缓解,不影响继续用药.结论：培美曲塞二钠联合铂类方案二线治疗晚期NSCLC安全有效,耐受性好.     

大蒜素对肺腺癌细胞侵袭生物学行为影响的初步研究

通过MTT法、细胞粘附试验、Transwell细胞迁移和侵袭试验检测不同浓度的大蒜素对肺腺癌细胞的活性、粘附、迁移与侵袭能力的变化;(RT-qPCR)逆转录-定量聚合酶链反应检测不同浓度的大蒜素对TIMP/MMP平衡的影响.本研究中发现大蒜素可呈剂量依赖性抑制肺腺癌细胞的活性、粘附、迁移和侵袭能力.大蒜素主要降低基质金...     

Early Diagnostic Value of Circulating MiRNA-21 in Lung Cancer： A Meta-Analysis

To evaluate the early diagnostic value of circulating miRNA-21 in diagnosis of lung cancer, databases such as Wan Fang, VIP, PubMed, and Elsevier were systematically searched from 2005 to 2013 to collect relevant references in which the diagnostic value had been evaluated. The statistics were consolidated and the qualities of the studies were classified. The data were analyzed using Meta Disc1.4 software. The diagnostic value of circulating miRNA-21 in lung cancer was assessed by pooling sensitivity, specificity, the likelihood ratio, and the Summary Receiver Operating Characteristic(SROC) curve. Publication biases of the studies involved were analyzed using Stata 11.0 software. A total of 143 papers were collected of which 8 were included, which contained 600 cases and440 controls. A heterogeneity test proved the existence of homogeneity in this study. Upon analysis using random effects models, the weighted sensitivity was 0.68, the specificity 0.77, the positive likelihood ratio 2.84, the negative likelihood ratio 0.40, and the SROC Area Under the Curve(AUC) was 0.8133. Further analysis by subgroup showed that the 5 indicators mentioned above were 0.72, 0.84, 4.50, 0.27, and 0.8987, respectively, for the serum group and 0.63, 0.70, 1.95, 0.53, and 0.7318, respectively, for the plasma group. We conclude that circulating miRNA-21can be regarded a valuable reference in diagnosis of lung cancer. This research showed that in lung cancer the early diagnostic value of miRNA-21 in serum was better than that in plasma.     

藏药四臣止咳颗粒剂抗菌抗病毒作用研究

目的:探讨藏药四臣止咳颗粒剂的抗菌、抗病毒作用。方法:采用二倍稀释法、平板转种法测定四臣止咳颗粒剂的最小抑菌浓度(MIC)及最小杀菌浓度(MBC),采用孙氏综合法测定四臣止咳颗粒剂对金黄色葡葡球菌ATCC25925株、流感嗜血杆菌58535株、甲型流行性感冒病毒FM1株、3型腺病毒标准株感染小鼠的半数保护量。结果:四臣止咳颗粒剂对试验所选用的458株临床分离菌株均有一定的抑制和灭活作用,对感染金黄色葡葡球菌ATCC25925株和感染流感嗜血杆菌58535株的小鼠及感染甲型流感病毒FM1株、3型腺病毒标准株的小鼠均有显著的保护作用。结论:四臣止咳颗粒剂具有明显的抗菌抗病毒作用。     

Tracking extended mucociliary transport activity of individual deposited particles: longitudinal synchrotron X‐ray imaging in live mice

To assess potential therapies for respiratory diseases in which mucociliary transit (MCT) is impaired, such as cystic fibrosis and primary ciliary dyskinesia, a novel and non‐invasive MCT quantification method has been developed in which the transit rate and behaviour of individual micrometre‐sized deposited particles are measured in live mice using synchrotron phase‐contrast X‐ray imaging. Particle clearance by MCT is known to be a two‐phase process that occurs over a period of minutes to days. Previous studies have assessed MCT in the fast‐clearance phase, ～20 min after marker particle dosing. The aim of this study was to non‐invasively image changes in particle presence and MCT during the slow‐clearance phase, and simultaneously determine whether repeat synchrotron X‐ray imaging of mice was feasible over periods of 3, 9 and 25 h. All mice tolerated the repeat imaging procedure with no adverse effects. Quantitative image analysis revealed that the particle MCT rate and the number of particles present in the airway both decreased with time. This study successfully demonstrated for the first time that longitudinal synchrotron X‐ray imaging studies are possible in live small animals, provided appropriate animal handling techniques are used and care is taken to reduce the delivered radiation dose.